Aspergillus species are emerging as a significant cause of pneumonia mortality in immune compromised hosts, with haematological spread being a rare and life-threatening complication. The central nervous system (CNS) as a site for extrapulmonary spread is rarer still. We report a case of CNS disseminated aspergillosis in a patient treated with corticosteroids and infliximab, an immunomodulatory agent commonly used in the treatment of inflammatory bowel disease, and review the available literature regarding this rare pathology.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jocn.2016.02.009 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!